Novel insights into the pathogenesis of uric acid nephrolithiasis

被引:169
作者
Maalouf, NM
Cameron, MA
Moe, OW
Sakhaee, K
机构
[1] Univ Texas, SW Med Ctr, Dept Internal Med, Charles & Jane Pak Ctr Mineral Metab & Clin Res, Dallas, TX 75390 USA
[2] Dept Vet Affairs Med Ctr, Med Serv, Dallas, TX USA
关键词
insulin resistance; uric acid nephrolithiasis; urine pH;
D O I
10.1097/00041552-200403000-00006
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Purpose of review The factors involved in the pathogenesis of uric acid nephrolithiasis are well known. A low urinary pH is the most significant element in the generation of stones, with hyperuricosuria being a less common finding. The underlying mechanism(s) responsible for these disturbances remain poorly characterized. This review summarizes previous knowledge and highlights some recent developments in the pathophysiology of low urine pH and hyperuricosuria. Recent findings Epidemiological and metabolic studies have indicated an association between uric acid nephrolithiasis and insulin resistance. Some potential mechanisms include impaired ammoniagenesis caused by resistance to insulin action in the renal proximal tubule, or substrate competition by free fatty acids. The evaluation of a large Sicilian kindred recently revealed a putative genetic locus linked to uric acid stone disease. The identification of novel complementary DNA has provided an interesting insight into the renal handling of uric acid, including one genetic cause of renal uric acid wasting. Summary The recognition of metabolic, molecular, and genetic factors that influence urinary pH, and uric acid metabolism and excretion, will provide novel insights into the pathogenesis of uric acid stones, and open the way for new therapeutic strategies.
引用
收藏
页码:181 / 189
页数:9
相关论文
共 67 条
[1]
ABATE N, IN PRESS KIDNEY INT
[2]
ABRAMSON RG, 1990, BASIC PRINCIPLES TRA, V3, P115
[4]
Asplin JR, 1996, SEMIN NEPHROL, V16, P412
[5]
Atsmon A, 1963, URIC ACID LITHIASIS
[6]
CIRCADIAN-RHYTHM OF URINARY PH IN MAN WITH AND WITHOUT CHRONIC ANTACID ADMINISTRATION [J].
AYRES, JW ;
WEIDLER, DJ ;
MACKICHAN, J ;
WAGNER, JG .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 12 (06) :415-420
[7]
Free fatty acids and pathogenesis of type 2 diabetes mellitus [J].
Bergman, RN ;
Ader, M .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2000, 11 (09) :351-356
[8]
URINE PH VARIATION DYNAMICS IN HEALTHY-INDIVIDUALS AND STONE FORMERS [J].
BILOBROV, VM ;
CHUGAJ, AV ;
BESSARABOV, VI .
UROLOGIA INTERNATIONALIS, 1990, 45 (06) :326-331
[9]
Insulin regulation of renal glucose metabolism in humans [J].
Cersosimo, E ;
Garlick, P ;
Ferretti, J .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1999, 276 (01) :E78-E84
[10]
Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney [J].
Cha, SH ;
Sekine, T ;
Fukushima, J ;
Kanai, Y ;
Kobayashi, Y ;
Goya, T ;
Endou, H .
MOLECULAR PHARMACOLOGY, 2001, 59 (05) :1277-1286